Artelo Biosciences, Inc. (ARTL)
NASDAQ·Healthcare·Biotechnology
$2.22
+0.68%
Mkt Cap $1.26M
No analyst coverage available
We don't have analyst ratings or price target data for Artelo Biosciences, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.